Westhouse Medical Services Plc
FRA:5WM ISIN:GB00B6YWDK49
Test for Breast Cancer and a patented procedure to treat glaucoma. www.westhousemedical.com
News
Breast cancer has become a major healthcare issue in the United Kingdom over the past two decades. Since the 1980s, breast cancer has received increasing attention throughout the world, due to the startling rise of the disease. The annual Breast Cancer Awareness month in October, which sees millions of pounds raised for research and charity, is testament to this.
Healthcare specialist Westhouse Medical Services Plc (FRA:5WM) today announces the immediate appointment of George Barry Jackson as a non-executive director of the company.
Since Westhouse Medical Services' (FRA:5WM) formation in July 2011, the company has been developing and growing at an exponential rate. In its initial six months of operation, it has acquired BreastCheck, a low cost non-invasive breast screening device, Profemme, a surgery / clinic based non-invasive testing device for Breast Cancer and also acquired AST Ambulance Service - a specialist Bariatric and Intensive Care patient transport service operating in the U.K.
Healthcare specialist Westhouse Medical Services Plc. (FRA:5WM) today announces it has entered into a US$2,000,000 cash and bond deal to acquire assets of Sunridge International. Sunridge will deliver the patents, manufacturing rights, distribution agreements and intellectual property for Pneumatic Trabeculoplasty (PNT) - the method of treatment and equipment used to treat glaucoma and ocular hypertension.
39,929 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 17) (Last 30 Days: 171) (Since Published: 20221)